For the Inventor, By the Inventor

Enter assignee name

Baranzate, Italy

Dipharma Francis S.r.l.

Calculating rank

USPTO Granted Patents = 39

% Expired Patents = 51.3

EPO Patents = 24

Trademarks = 2

Forward Citations = 18

Loading Chart...

Loading Chart...

53 inventors (with patents filed for the assignee):

Pietro Allegrini (23 out of 65 patents)

Gabriele Razzetti (20 out of 35 patents)

Emanuele Attolino (17 out of 20 patents)

4. Alessandro Restelli (6 out of 6 patents)

5. Chiara Vladiskovic (6 out of 6 patents)

6. Renzo Graziosi (4 out of 4 patents)

7. Simone Mantegazza (4 out of 8 patents)

8. Vittorio Lucchini (4 out of 10 patents)

9. Davide Rossi (3 out of 3 patents)

10. Andrea Malvestiti (3 out of 3 patents)

11. Giuseppe Barreca (2 out of 25 patents)

12. Luca Giannotti (2 out of 2 patents)

13. Alessandro Lombardo (2 out of 2 patents)

14. Enrico Brunoldi (2 out of 2 patents)

15. Mario Michieletti (2 out of 2 patents)

Core Competencies:

Glycoconjugate Derivatives

Farnesoid X Receptor Agonist

Selegiline Base

Topical Anti-Inflammatory Agent

Dexlansoprazole

Piperidine Compounds

Antimuscarinic Compound

Azapiridine

Antidepressant Compound

Sitagliptin

Pregabalin

Ziprasidone

39 patents: Sort by Forward Citations

1. 11401297 - Synthesis of glycoconjugate derivatives of a bile acid (2022-08-02),

2. 10752654 - Method for preparing a farnesoid X receptor agonist (2020-08-25),

3. 10597410 - Intermediates and process for the preparation of a crystalline form of a topical anti-inflammatory agent (2020-03-24),

4. 10597351 - Method for preparing selegiline base (2020-03-24),

5. 10370359 - Process for the preparation of crystalline dexlansoprazole (2019-08-06),

6. 9932321 - Process for the preparation of piperidine compounds (2018-04-03),

7. 9776953 - Isolation and purification of 6-aminocaproic acid (2017-10-03),

8. 9751828 - Antimuscarinic compound having a low content of impurities (2017-09-05),

9. 9708263 - Synthesis of an azasugar and the intermediates thereof (2017-07-18),

10. 9687484 - Crystalline forms of an antidepressant compound (2017-06-27),

11. 9550743 - Process for the preparation of an antidepressant and the intermediates thereof (2017-01-24),

12. 9334223 - Process for the purification of 2-phenyl-2-methyl-propanoic acid derivatives (2016-05-10),

13. 9079856 - Synthesis of a glycosyltransferase inhibitor (2015-07-14),

14. 9079831 - Process for the preparation of sulfonamide compounds (2015-07-14),

15. 8969561 - Apixaban preparation process (2015-03-03),

Company Overview

Dipharma Francis S.r.l. is a prominent player in the pharmaceutical industry, specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company is known for its expertise in complex synthesis and offers a range of products tailored for various therapeutic areas. Based in Baranzate, Italy, Dipharma is committed to innovation and quality, serving both domestic and international markets while adhering to stringent regulatory standards.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

39 Patents

#1 in Baranzate

#244 in Italy

#17,465 in the World

Baranzate, Italy

Dipharma Francis S.r.l.

Forward Citations = 18

53 inventors:

Pietro Allegrini (23 out of 65 patents)

Gabriele Razzetti (20 out of 35 patents)

Emanuele Attolino (17 out of 20 patents)

4. Alessandro Restelli (6 out of 6 patents)

5. Chiara Vladiskovic (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dipharma Francis S.r.l.. Retrieved from https://idiyas.com/company/dipharma-francis-s-r-l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…